WDBG Projected Dividend Yield

Woodbrook Group Holdings Inc ( OTCBB : WDBG )

Woodbrook Group Holdings is engaged in developing, marketing and distributing branded and generic pharmaceutical products primarily in the cough and cold markets. Co.'s subsidiary, MCR American Pharmaceuticals, Inc., focuses on the acquisition, development, marketing and distribution of cough and cold, prenatal and pain management pharmaceutical products that provide quick and low-cost market entry through the Abbreviated New Drug Application, and Over-The-Counter monograph regulatory approval pathways. Co.'s subsidiary, AMBI Pharmaceuticals, Inc., focuses on the distribution of generic equivalent pharmaceutical products to pharmaceutical wholesalers, distributors and chain pharmacies.

20 YEAR PERFORMANCE RESULTS